Risk factors

Heavy geographic and loan concentration in construction, multifamily, and non-residential real estate within the New York and Boston metropolitan areas. Significant reliance on wholesale funding sources including brokered deposits, military deposits, and listing services. Substantial exposure to interest rate risk, cybersecurity threats, and extensive regulatory oversight.

Rental income, property values, and distributions depend on multifamily and commercial real estate performance.

Nektar Therapeutics faces heavy reliance on rezpegaldesleukin and partnership execution amid ongoing net losses totaling $119.0 million in 2024. Clinical trials, regulatory hurdles, single-source suppliers, and complex intellectual property litigation dominate the risk profile.

Defense segment relies heavily on U.S. government contracts, subject to budget changes and fixed-price cost pressures. Housewares and safety segments depend on Asian and Mexican third-party manufacturing partners. Housewares sales concentrate heavily in the U.S. holiday retail season with key customers.

Nexalin faces severe going concern doubts, with ongoing operating losses and a cash loss of $7,607,290 for 2024. The company relies heavily on clinical trials, third-party collaborators in China, and raising capital through equity offerings. Operations are exposed to extensive Chinese regulatory, legal, and currency conversion risks.

Oragenics faces substantial going concern doubt with an accumulated deficit of $217 million and negative cash flows.

Earnings depend heavily on net interest spread and macroeconomic interest rate fluctuations set by the Federal Reserve. Growth strategy targets small to medium-sized businesses with fewer financial resources during economic downturns. Operations face intense competition from diverse financial institutions and rapid technological change in the industry. Credit exposure, loan losses, and potential security breaches or fraud threaten financial condition.

The Trust's income depends entirely on commodity prices and underlying operator performance.

Purple faces substantial liquidity pressure, recurring operating losses, and significant debt obligations held largely by controlling stockholder Coliseum Capital.

RideNow Group's risk profile centers on inventory access from OEMs, heavy reliance on third-party financing, and weather concentration in Arizona, Florida, and Texas.

Repligen faces intense bioprocessing competition from major players like Danaher and Thermo Fisher. Growth relies heavily on acquisitions and new product development. International operations expose the company to currency fluctuations and geopolitical risks.

Red River Bancshares operates as a community bank heavily concentrated in Louisiana markets and vulnerable to regional weather disasters. The bank faces significant credit concentration risks in commercial real estate, residential mortgages, and health care loans. Its profitability depends heavily on net interest margins and managing localized economic downturns.